Drugs / VRC-FLUDNA056-00-VP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00995982 | Oct 2009 → Sep 2010 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VRC-FLUDNA056-00-VP | “The VRC-FLUDNA056-00-VP vaccine was developed and manufactured by VRC, NIAID.” NCT00995982 ↗ |
| Modality | Vaccine | “experimental DNA vaccine for seasonal influenza” NCT00995982 ↗ |
| Route | Intramuscular | “All injections will be administered intramuscularly (IM) in the deltoid muscle.” NCT00995982 ↗ |